What is the AI in life sciences market size forecast for 2030?

The global AI in life sciences market is projected to reach $14.8 billion by 2030, growing from $2.9 billion in 2025 at a 38.7% CAGR. Drug discovery represents 42% of the market, followed by clinical trials optimization (23%) and precision medicine (20%).

Which companies lead the AI life sciences market?

Leading companies include Insilico Medicine (AI drug discovery), Recursion Pharmaceuticals (biological imaging AI), Exscientia (precision medicine), and Tempus (clinical diagnostics). Big pharma players like Pfizer, Novartis, Roche, and Merck are major AI investors through partnerships and acquisitions.

Which regions have the largest AI life sciences markets?

North America leads with 45% market share (42% U.S. alone), followed by Europe at 28% (led by Germany, UK, Switzerland) and Asia-Pacific at 22% (China 15%, with Japan, South Korea, and India growing rapidly). Asia-Pacific is the fastest-growing region at 45% CAGR.

What are the main applications of AI in life sciences?

Primary applications include drug discovery and development (42% of market), clinical trials optimization (23%), precision medicine and diagnostics (20%), and pharmaceutical manufacturing. AI reduces drug discovery timelines from 4-5 years to under 18 months.

How much investment is flowing into AI life sciences?

Venture capital investment totaled $12.4 billion globally during 2024-2025, with U.S. startups capturing 60%. Major deals include Novartis-Isomorphic Labs ($1.2B partnership), Merck-Prometheus ($10.8B acquisition), and Pfizer-Seagen ($43B acquisition with AI integration).

AI in Life Sciences Market Size, Trends and Forecast Statistics by Company and Country 2026-2030

Comprehensive market analysis of AI in life sciences covering market size projections, growth trends, leading companies, and regional breakdowns from 2026 to 2030 with detailed forecast statistics.

Published: December 10, 2025 By Marcus Rodriguez Category: Biotech

The integration of artificial intelligence into life sciences is creating one of the fastest-growing technology markets of the decade. From drug discovery acceleration to personalized medicine and clinical trial optimization, AI is fundamentally reshaping how pharmaceutical companies, biotech firms, and research institutions approach healthcare innovation.

Executive Summary

The global AI in life sciences market is projected to grow from $2.9 billion in 2025 to $14.8 billion by 2030, representing a compound annual growth rate (CAGR) of 38.7% according to Grand View Research. North America dominates with 45% market share, followed by Europe at 28% and Asia-Pacific at 22%. McKinsey & Company estimates that AI could generate $100 billion annually in value for the pharmaceutical industry alone through accelerated R&D, optimized manufacturing, and improved clinical outcomes.

Global AI Life Sciences Market Forecast 2026-2030

...

Read the full article at AI BUSINESS 2.0 NEWS

Year	Market Size (USD Billion)	YoY Growth	Key Driver
2026	$4.1B	41.4%	Drug Discovery AI
2027	$5.7B	39.0%	Clinical Trials Optimization
2028	$7.9B	38.6%	Precision Medicine
2029	$10.9B	38.0%